Boothbay Fund Management’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-14,317
| Closed | -$209K | – | 1911 |
|
|
2022
Q2 | $209K | Sell |
14,317
-36,398
| -72% | -$531K | 0.01% | 1469 |
|
|
2022
Q1 | $1.01M | Hold |
50,715
| – | – | 0.02% | 712 |
|
|
2021
Q4 | $887K | Buy |
50,715
+11,681
| +30% | +$204K | 0.02% | 690 |
|
|
2021
Q3 | $306K | Buy |
39,034
+2,737
| +8% | +$21.5K | 0.01% | 1098 |
|
|
2021
Q2 | $120K | Sell |
36,297
-5,942
| -14% | -$19.6K | ﹤0.01% | 1535 |
|
|
2021
Q1 | $230K | Buy |
42,239
+16,964
| +67% | +$92.4K | 0.01% | 1081 |
|
|
2020
Q4 | $355K | Buy |
25,275
+592
| +2% | +$8.32K | 0.01% | 740 |
|
|
2020
Q3 | $293K | Buy |
24,683
+7,689
| +45% | +$91.3K | 0.02% | 695 |
|
|
2020
Q2 | $256K | Buy |
+16,994
| New | +$256K | 0.02% | 624 |
|
|
2019
Q3 | – | Sell |
-3,702
| Closed | -$264K | – | 653 |
|
|
2019
Q2 | $264K | Buy |
+3,702
| New | +$264K | 0.02% | 460 |
|